Qiu Kai, Obianwuna Uchechukwu Edna, Wang Jing, Zhang Hai-Jun, Qi Guang-Hai, Wu Shu-Geng
Risk Assessment Laboratory of Feed Derived Factors to Animal Product Quality Safety of Ministry of Agriculture & Rural Affairs, National Engineering Research Center of Biological Feed, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, China.
Front Vet Sci. 2021 Oct 11;8:745565. doi: 10.3389/fvets.2021.745565. eCollection 2021.
In the context of increasing awareness on the dietary supplementation of organic selenium in commercial poultry production and ensuring safe egg production, the present study investigated the effects of selenium on the pharmacokinetics of the therapeutic use of florfenicol and enrofloxacin from perspectives of laying performance, selenium deposition in eggs, and drug residue in plasma, organs, and eggs. A 2 × 3 factorial arrangement with two kinds of drugs (florfenicol vs. enrofloxacin, 200 mg/kg) and three levels of dietary organic selenium SCIP (selenium conjugated to insect protein) (0, 2, and 5 mg/kg) was designed together with a blank control group. Healthy Hy-Line Brown laying hens ( = 252, 40-week-old and 90.0 ± 1.7% of egg production rate) were randomly allocated into one of seven treatments with six replicates and six hens per replicate. The experiment lasted for 42 days and consisted of three periods (adjusted stage, depositional stage, and eliminating stage) of 14 days each. These stages entail feeding of the laying hens with basal diets, addition of drugs and selenium synchronously into the diets, drug withdrawal from diet, and supply of selenium uninterruptedly in the diet. Egg production and feed intake were recorded on daily and weekly bases, respectively. The selenium content in egg yolk, egg white, and whole eggs and the drug residues in eggs, plasma, liver, kidney, and breast muscle were determined on days 2, 3, 5, 6, 7, 9, 11, and 14 of the depositional and eliminating stages. There was no significant difference ( > 0.05) in egg production among the dietary treatments, but feed intake decreased significantly ( < 0.05) in the drug treatment group compared to other groups. Dietary organic selenium decreased the residue of drugs in tissues and eggs, while the metabolism and deposition of selenium in laying hens were suppressed due to drug effects. The results of the present study are of significance to enrich the knowledge of the pharmacokinetics of florfenicol and enrofloxacin in laying hens and ensure the quality of poultry products.
在商业家禽生产中,人们对有机硒膳食补充剂的认识不断提高,且要确保鸡蛋安全生产,在此背景下,本研究从产蛋性能、鸡蛋中硒的沉积以及血浆、器官和鸡蛋中的药物残留等角度,研究了硒对氟苯尼考和恩诺沙星治疗用途药代动力学的影响。设计了一个2×3析因试验,包括两种药物(氟苯尼考与恩诺沙星,200毫克/千克)和三个水平的膳食有机硒SCIP(与昆虫蛋白结合的硒)(0、2和5毫克/千克),同时设置一个空白对照组。将健康的海兰褐蛋鸡(n = 252,40周龄,产蛋率90.0±1.7%)随机分为七个处理组之一,每个处理组有六个重复,每个重复六只母鸡。试验持续42天,包括三个各为期14天的阶段(调整期、沉积期和消除期)。这些阶段包括给蛋鸡饲喂基础日粮、在日粮中同步添加药物和硒、停止在日粮中添加药物以及在日粮中持续供应硒。分别每日和每周记录产蛋量和采食量。在沉积期和消除期的第2、3、5、6、7、9、11和14天,测定蛋黄、蛋清和全蛋中的硒含量以及鸡蛋、血浆、肝脏、肾脏和胸肌中的药物残留。各日粮处理间的产蛋量无显著差异(P>0.05),但与其他组相比,药物处理组的采食量显著降低(P<0.05)。日粮有机硒降低了组织和鸡蛋中的药物残留,而由于药物作用,蛋鸡体内硒的代谢和沉积受到抑制。本研究结果对于丰富氟苯尼考和恩诺沙星在蛋鸡体内的药代动力学知识以及确保禽产品质量具有重要意义。